PetMed Express, Inc. (NASDAQ:PETS) Director Gian Fulgoni sold 20,000 shares of the company’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $44.38, for a total transaction of $887,600.00. Following the completion of the sale, the director now directly owns 55,900 shares in the company, valued at $2,480,842. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Shares of PetMed Express, Inc. (NASDAQ:PETS) traded up $2.02 during trading hours on Thursday, reaching $51.68. 641,353 shares of the company’s stock were exchanged, compared to its average volume of 491,907. PetMed Express, Inc. has a 12-month low of $19.21 and a 12-month high of $52.20. The company has a market capitalization of $1,060.00, a price-to-earnings ratio of 34.68, a PEG ratio of 2.87 and a beta of 1.12.
PetMed Express (NASDAQ:PETS) last released its quarterly earnings data on Monday, October 23rd. The company reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.30 by $0.13. PetMed Express had a net margin of 11.58% and a return on equity of 31.46%. The company had revenue of $66.70 million during the quarter, compared to analyst estimates of $63.41 million. During the same period last year, the business earned $0.24 earnings per share. PetMed Express’s revenue was up 9.7% compared to the same quarter last year. analysts anticipate that PetMed Express, Inc. will post 1.68 earnings per share for the current fiscal year.
Several hedge funds have recently added to or reduced their stakes in the company. North Star Investment Management Corp. lifted its position in PetMed Express by 22.3% during the fourth quarter. North Star Investment Management Corp. now owns 95,842 shares of the company’s stock valued at $4,361,000 after purchasing an additional 17,501 shares during the last quarter. GSA Capital Partners LLP bought a new stake in PetMed Express during the third quarter valued at approximately $1,094,000. Cubist Systematic Strategies LLC bought a new stake in PetMed Express during the third quarter valued at approximately $1,125,000. Uniplan Investment Counsel Inc. lifted its position in PetMed Express by 76.9% during the third quarter. Uniplan Investment Counsel Inc. now owns 333,220 shares of the company’s stock valued at $11,046,000 after purchasing an additional 144,903 shares during the last quarter. Finally, AMP Capital Investors Ltd bought a new stake in PetMed Express during the third quarter valued at approximately $564,000. Institutional investors own 99.88% of the company’s stock.
Several research analysts recently issued reports on the stock. Credit Suisse Group reissued an “underperform” rating and set a $19.00 target price on shares of PetMed Express in a research note on Monday, October 2nd. Noble Financial reiterated a “hold” rating on shares of PetMed Express in a report on Friday, October 27th. ValuEngine downgraded shares of PetMed Express from a “buy” rating to a “hold” rating in a report on Monday, October 2nd. Zacks Investment Research upgraded shares of PetMed Express from a “sell” rating to a “hold” rating and set a $50.00 target price for the company in a report on Friday, October 20th. Finally, Northcoast Research set a $58.00 price objective on shares of PetMed Express and gave the stock a “buy” rating in a report on Wednesday, January 3rd. One analyst has rated the stock with a sell rating, four have given a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. PetMed Express has an average rating of “Hold” and a consensus price target of $42.80.
COPYRIGHT VIOLATION NOTICE: This article was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another website, it was stolen and reposted in violation of international trademark and copyright laws. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/11/petmed-express-inc-pets-director-gian-fulgoni-sells-20000-shares-of-stock.html.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.